Universitätsklinikum Tübingen

Beyond the Scale: The Hidden Burden of Underweight and Cachexia in Adults with Congenital Heart Defects and Heart Failure—Results from the Pathfinder CHD-Registry (2025) Kaemmerer-Suleiman AS, Freilinger S, Freiberger A, Dewald O, Achenbach S, Bischoff G, Engel A, et al. Journal article Approaches to Invasive Fungal Diseases in Paediatric Cancer Centres: An Analysis of Current Practices and Challenges in Germany, Austria and Switzerland (2025) Seidel D, Pana ZD, Ebrahimi-Fakhari D, Butzer SK, Mehler K, Reinhold I, Simon A, et al. Journal article Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO/ARO/AIO-16): an open-label, multicentre, single-arm, phase 2 trial (2025) Gani C, Fokas E, Polat B, Ott O, Diefenhardt M, Königsrainer A, Böke S, et al. Journal article Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast cancer with increased recurrence risk (2025) Müller V, Hörner M, Thill M, Banys-Paluchowski M, Schmatloch S, Fasching P, Harbeck N, et al. Journal article VGLL fusions define a new class of intraparenchymal central nervous system schwannoma (2025) Schmid S, Mirchia K, Tietze A, Liu I, Siewert C, Nückles J, Schittenhelm J, et al. Journal article Update Breast Cancer 2024 Part 3 – Patients with Advanced Stage Breast Cancer (2025) Lüftner D, Kolberg HC, Hartkopf AD, Fehm TN, Welslau M, Müller V, Schütz F, et al. Journal article, Review article Update Breast Cancer 2024 Part 2 – Patients with Early Stage Breast Cancer (2025) Janni W, Kolberg HC, Hartkopf AD, Fehm TN, Welslau M, Müller V, Schütz F, et al. Journal article, Review article Neoadjuvant Paclitaxel/Olaparib in Comparison to Paclitaxel/Carboplatin in Patients with HER2-Negative Breast Cancer and HRD-Long-term Survival of the GeparOLA Study (2025) Fasching P, Schmatloch S, Hauke J, Rey J, Jackisch C, Klare P, Link T, et al. Journal article Neutrophil-To-lymphocyte ratio as a biomarker for clinical response after autologous haematopoietic stem cell transplantation in systemic sclerosis (2025) Keret S, Kaly L, Schett G, Bergmann C, Feldman E, Zuckerman T, Yehudai-Ofir D, et al. Journal article A risk score to predict kidney survival in patients with autosomal recessive polycystic kidney disease at the age of two months (2025) Burgmaier K, Kilian S, Arbeiter K, Atmis B, Boyer O, Buescher A, Dursun I, et al. Journal article